Антибиотики и Химиотерапия (May 2020)

Studying the Effectiveness of Lariphan® in the Experimental Form Severe Acute Respiratory Syndrome

  • S. Ya. Loginova,
  • V. N. Shchukina,
  • S. V. Borisevich,
  • R. A. Hamitov,
  • V. A. Maksimov

DOI
https://doi.org/10.24411/0235-2990-2019-100025
Journal volume & issue
Vol. 64, no. 5-6
pp. 13 – 17

Abstract

Read online

Studies have been carried out to study the effectiveness of the high-molecular inducer of interferon Larifan® in relation to the experimental form of severe acute respiratory syndrome in Syrian hamsters. It is shown that Lariphan® is effective when applied in a preventive scheme, and the scheme of emergency prevention. The coefficient of therapeutic action for virological, hematological and biochemical parameters was 57.5 and 65.0%, respectively (ð

Keywords